AI in Biopharma Innovation and Regulatory Cha...

Alert volume inside IT operations has outpaced manual triage, leaving real incidents buried in noise. In this episode, Dhrubojyoti Das Deb, SVP of Global IT at JPMorgan Chase & Co., explores how AI-driven correlation and intelligent grouping can turn thousands of alerts into a ha ...  Show more

Enterprise CX teams have poured budget into AI, yet many still can't show measurable returns — frontline staff double-check the tools, and each new bot becomes another disconnected silo. ​ In this episode, John McMullan, Head of Product Marketing and Strategy at Observe.AI, joins ...  Show more

Daphne Koller is the founder and CEO of insitro, a company using AI and machine learning to engineer drug discovery. In this conversation with a16z's Vijay Pande, she discusses how an LLM for cells could revolutionize drug discovery and how to bridge the technological and cultura ...  Show more

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more